STOCK TITAN

[Form 4] Kewaunee Scientific Corp Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Kewaunee Scientific Corp (KEQU) reported a Form 4 filing disclosing equity transactions for Douglas J. Batdorff, VP of Manufacturing Operations. On June 25, 2025, Batdorff was granted 4,528 Restricted Stock Units (RSUs) under the FY26 program.

The RSU grant is structured in two components:

  • 50% Service-Based RSUs: Vesting in three equal annual installments starting June 30, 2026, contingent on continued employment
  • 50% Performance-Based RSUs: Vesting subject to achieving performance goals over a three-year period

Each RSU represents the right to receive one share of Kewaunee Scientific common stock. The grant was made at $0 cost to the executive. The ultimate number of shares received will depend on continued employment and performance metrics over the three-year period.

Kewaunee Scientific Corp (KEQU) ha comunicato tramite un modulo Form 4 le transazioni azionarie di Douglas J. Batdorff, Vicepresidente delle Operazioni di Produzione. Il 25 giugno 2025, a Batdorff sono state assegnate 4.528 Restricted Stock Units (RSU) nell'ambito del programma FY26.

Il premio in RSU è suddiviso in due componenti:

  • 50% RSU basate sul servizio: maturazione in tre rate annuali uguali a partire dal 30 giugno 2026, subordinata alla permanenza in servizio
  • 50% RSU basate sulle performance: maturazione condizionata al raggiungimento di obiettivi di performance su un periodo di tre anni

Ogni RSU conferisce il diritto a ricevere una azione ordinaria di Kewaunee Scientific. L'assegnazione è stata effettuata senza alcun costo per il dirigente. Il numero finale di azioni ricevute dipenderà dalla continuità lavorativa e dal raggiungimento degli obiettivi di performance nel periodo triennale.

Kewaunee Scientific Corp (KEQU) informó mediante un formulario Form 4 sobre transacciones de acciones realizadas por Douglas J. Batdorff, Vicepresidente de Operaciones de Manufactura. El 25 de junio de 2025, a Batdorff se le otorgaron 4,528 Unidades de Acciones Restringidas (RSU) bajo el programa FY26.

La concesión de RSU está estructurada en dos componentes:

  • 50% RSU basadas en servicio: se consolidan en tres cuotas anuales iguales a partir del 30 de junio de 2026, condicionadas a la continuidad laboral
  • 50% RSU basadas en desempeño: consolidación sujeta al cumplimiento de metas de desempeño durante un periodo de tres años

Cada RSU representa el derecho a recibir una acción común de Kewaunee Scientific. La concesión fue otorgada sin costo para el ejecutivo. La cantidad final de acciones recibidas dependerá de la continuidad laboral y del cumplimiento de los objetivos de desempeño durante el periodo de tres años.

Kewaunee Scientific Corp (KEQU)는 제조 운영 부사장인 Douglas J. Batdorff의 주식 거래 내역을 Form 4 제출을 통해 보고했습니다. 2025년 6월 25일, Batdorff에게 FY26 프로그램에 따라 4,528개의 제한 주식 단위(RSUs)가 부여되었습니다.

RSU 부여는 두 가지 구성 요소로 나뉩니다:

  • 50% 서비스 기반 RSU: 2026년 6월 30일부터 3년에 걸쳐 매년 동일한 비율로 베스팅되며, 계속 근무 조건이 붙습니다
  • 50% 성과 기반 RSU: 3년간 성과 목표 달성 여부에 따라 베스팅됩니다

각 RSU는 Kewaunee Scientific 보통주 1주를 받을 권리를 의미합니다. 이 부여는 경영진에게 비용 없이 이루어졌습니다. 최종 수령 주식 수는 3년간의 근속 및 성과 지표에 따라 결정됩니다.

Kewaunee Scientific Corp (KEQU) a déclaré, via un formulaire Form 4, des transactions sur actions concernant Douglas J. Batdorff, vice-président des opérations de fabrication. Le 25 juin 2025, Batdorff s'est vu attribuer 4 528 unités d'actions restreintes (RSU) dans le cadre du programme FY26.

L'attribution des RSU est divisée en deux volets :

  • 50% RSU basées sur le service : acquisition en trois versements annuels égaux à partir du 30 juin 2026, sous condition de maintien en emploi
  • 50% RSU basées sur la performance : acquisition soumise à l'atteinte d'objectifs de performance sur une période de trois ans

Chaque RSU donne droit à une action ordinaire de Kewaunee Scientific. L'attribution a été effectuée sans coût pour le dirigeant. Le nombre final d'actions reçues dépendra de la poursuite de l'emploi et des résultats de performance sur la période triennale.

Kewaunee Scientific Corp (KEQU) meldete in einer Form 4 Einreichung Aktiengeschäfte von Douglas J. Batdorff, Vizepräsident der Fertigungsabläufe. Am 25. Juni 2025 wurden Batdorff 4.528 Restricted Stock Units (RSUs) im Rahmen des FY26-Programms gewährt.

Die RSU-Zuteilung ist in zwei Komponenten unterteilt:

  • 50% Dienstleistungsbasierte RSUs: Vesting in drei gleichen jährlichen Raten ab dem 30. Juni 2026, abhängig von fortgesetzter Anstellung
  • 50% Leistungsbasierte RSUs: Vesting abhängig vom Erreichen von Leistungszielen über einen Zeitraum von drei Jahren

Jede RSU berechtigt zum Erhalt einer Aktie der Kewaunee Scientific Stammaktien. Die Zuteilung erfolgte für den Manager ohne Kosten. Die endgültige Anzahl der erhaltenen Aktien hängt von der fortgesetzten Beschäftigung und den Leistungskriterien über den Dreijahreszeitraum ab.

Positive
  • VP of Manufacturing Operations received 4,528 restricted stock units with 50% performance-based vesting, aligning executive compensation with long-term company performance and shareholder interests
Negative
  • None.

Kewaunee Scientific Corp (KEQU) ha comunicato tramite un modulo Form 4 le transazioni azionarie di Douglas J. Batdorff, Vicepresidente delle Operazioni di Produzione. Il 25 giugno 2025, a Batdorff sono state assegnate 4.528 Restricted Stock Units (RSU) nell'ambito del programma FY26.

Il premio in RSU è suddiviso in due componenti:

  • 50% RSU basate sul servizio: maturazione in tre rate annuali uguali a partire dal 30 giugno 2026, subordinata alla permanenza in servizio
  • 50% RSU basate sulle performance: maturazione condizionata al raggiungimento di obiettivi di performance su un periodo di tre anni

Ogni RSU conferisce il diritto a ricevere una azione ordinaria di Kewaunee Scientific. L'assegnazione è stata effettuata senza alcun costo per il dirigente. Il numero finale di azioni ricevute dipenderà dalla continuità lavorativa e dal raggiungimento degli obiettivi di performance nel periodo triennale.

Kewaunee Scientific Corp (KEQU) informó mediante un formulario Form 4 sobre transacciones de acciones realizadas por Douglas J. Batdorff, Vicepresidente de Operaciones de Manufactura. El 25 de junio de 2025, a Batdorff se le otorgaron 4,528 Unidades de Acciones Restringidas (RSU) bajo el programa FY26.

La concesión de RSU está estructurada en dos componentes:

  • 50% RSU basadas en servicio: se consolidan en tres cuotas anuales iguales a partir del 30 de junio de 2026, condicionadas a la continuidad laboral
  • 50% RSU basadas en desempeño: consolidación sujeta al cumplimiento de metas de desempeño durante un periodo de tres años

Cada RSU representa el derecho a recibir una acción común de Kewaunee Scientific. La concesión fue otorgada sin costo para el ejecutivo. La cantidad final de acciones recibidas dependerá de la continuidad laboral y del cumplimiento de los objetivos de desempeño durante el periodo de tres años.

Kewaunee Scientific Corp (KEQU)는 제조 운영 부사장인 Douglas J. Batdorff의 주식 거래 내역을 Form 4 제출을 통해 보고했습니다. 2025년 6월 25일, Batdorff에게 FY26 프로그램에 따라 4,528개의 제한 주식 단위(RSUs)가 부여되었습니다.

RSU 부여는 두 가지 구성 요소로 나뉩니다:

  • 50% 서비스 기반 RSU: 2026년 6월 30일부터 3년에 걸쳐 매년 동일한 비율로 베스팅되며, 계속 근무 조건이 붙습니다
  • 50% 성과 기반 RSU: 3년간 성과 목표 달성 여부에 따라 베스팅됩니다

각 RSU는 Kewaunee Scientific 보통주 1주를 받을 권리를 의미합니다. 이 부여는 경영진에게 비용 없이 이루어졌습니다. 최종 수령 주식 수는 3년간의 근속 및 성과 지표에 따라 결정됩니다.

Kewaunee Scientific Corp (KEQU) a déclaré, via un formulaire Form 4, des transactions sur actions concernant Douglas J. Batdorff, vice-président des opérations de fabrication. Le 25 juin 2025, Batdorff s'est vu attribuer 4 528 unités d'actions restreintes (RSU) dans le cadre du programme FY26.

L'attribution des RSU est divisée en deux volets :

  • 50% RSU basées sur le service : acquisition en trois versements annuels égaux à partir du 30 juin 2026, sous condition de maintien en emploi
  • 50% RSU basées sur la performance : acquisition soumise à l'atteinte d'objectifs de performance sur une période de trois ans

Chaque RSU donne droit à une action ordinaire de Kewaunee Scientific. L'attribution a été effectuée sans coût pour le dirigeant. Le nombre final d'actions reçues dépendra de la poursuite de l'emploi et des résultats de performance sur la période triennale.

Kewaunee Scientific Corp (KEQU) meldete in einer Form 4 Einreichung Aktiengeschäfte von Douglas J. Batdorff, Vizepräsident der Fertigungsabläufe. Am 25. Juni 2025 wurden Batdorff 4.528 Restricted Stock Units (RSUs) im Rahmen des FY26-Programms gewährt.

Die RSU-Zuteilung ist in zwei Komponenten unterteilt:

  • 50% Dienstleistungsbasierte RSUs: Vesting in drei gleichen jährlichen Raten ab dem 30. Juni 2026, abhängig von fortgesetzter Anstellung
  • 50% Leistungsbasierte RSUs: Vesting abhängig vom Erreichen von Leistungszielen über einen Zeitraum von drei Jahren

Jede RSU berechtigt zum Erhalt einer Aktie der Kewaunee Scientific Stammaktien. Die Zuteilung erfolgte für den Manager ohne Kosten. Die endgültige Anzahl der erhaltenen Aktien hängt von der fortgesetzten Beschäftigung und den Leistungskriterien über den Dreijahreszeitraum ab.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Batdorff Douglas J.

(Last) (First) (Middle)
2700 WEST FRONT STREET

(Street)
STATESVILLE NC 28677

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
KEWAUNEE SCIENTIFIC CORP /DE/ [ KEQU ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP of Manufacturing Operations
3. Date of Earliest Transaction (Month/Day/Year)
06/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units FY26 (1) 06/25/2025 A 4,528 (2) (2) Common Stock 4,528 $0 4,528 D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
2. The award of restricted stock units shall vest as follows: (a) 50% of the number of restricted stock units subject to the award consist of service-based restricted stock units that vest in three equal annual installments beginning June 30, 2026, subject to the reporting person's continued employment with the Company; and (b) 50% of the number of restricted stock units subject to the award consist of performance-based restricted stock units that will vest only if performance goals are achieved over a three-year period. The actual number of units (if any) received under this award will depend on continued employment and actual performance over the three-year performance period.
Remarks:
/s/ Donald T. Gardner III, Attorney-in-fact 06/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many restricted stock units (RSUs) did KEQU's VP of Manufacturing Operations receive on June 25, 2025?

Douglas J. Batdorff, KEQU's VP of Manufacturing Operations, received 4,528 restricted stock units on June 25, 2025.

What is the vesting schedule for KEQU's 2026 restricted stock units granted to Douglas Batdorff?

The RSUs have a split vesting schedule: 50% are service-based units vesting in three equal annual installments starting June 30, 2026, and 50% are performance-based units that vest only if performance goals are achieved over a three-year period.

What was the purchase price of the restricted stock units granted to KEQU's VP of Manufacturing Operations?

The restricted stock units were granted at $0 cost to Douglas Batdorff, as indicated in the Form 4 filing's price column.

Who is authorized to sign Form 4 filings for KEQU's VP of Manufacturing Operations?

Donald T. Gardner III signed the Form 4 filing as Attorney-in-fact for Douglas J. Batdorff on June 27, 2025.

Where is KEQU's VP of Manufacturing Operations Douglas Batdorff based?

Douglas J. Batdorff's business address is listed as 2700 West Front Street, Statesville, NC 28677.
Kewaunee Scienti

NASDAQ:KEQU

KEQU Rankings

KEQU Latest News

KEQU Latest SEC Filings

KEQU Stock Data

105.36M
2.13M
24.44%
44.44%
1.62%
Furnishings, Fixtures & Appliances
Laboratory Apparatus & Furniture
Link
United States
STATESVILLE